CompletedNot Applicable

Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer

Austria30 participantsStarted 2020-06-08

Plain-language summary

The purpose of this study is to determine whether any eventual skin damage caused by radiation therapy can be detected and monitored at a subclinical level via optical coherence tomography (OCT). Another key question is whether subclinical OCT detected skin damage correlates with acute and late clinical toxicity.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with cancer located at: nasopharynx, oropharynx, hypopharynx, larynx, oral cavity and definitive or adjuvant radiation- or radio-chemotherapy Exclusion Criteria: * reduced mental capacity * treatment with C225 Cetuximab * bearded patients * overt skin disease * vast tattoos in the neck region

What they're measuring

early radiation induced skin structure changes detected in OCT

Timeframe: First week of radiation therapy

Trial details

NCT IDNCT04610645

SponsorKrankenhaus Barmherzige Schwestern Linz

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-08

View on ClinicalTrials.gov More Head and Neck Cancer trials